NovaBay Pharmaceuticals Stock Quote NBY - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.1199

Bid

Ask

Volume

113,037

2.07 Day's Range 2.31

2.0501 52 Week Range 44.80

Market Cap

2.649M

Previous Close

2.30

Open

2.31

Last Trade

2.1006

Last Trade Time

17:07:23

Financial Volume

$ 243,148

VWAP

2.1511

Average Volume (3m)

9,216,022

Shares Outstanding

1,151,715

Dividend Yield

PE Ratio

-0.15

Earnings Per Share (EPS)

-14.5

Revenue

14.73M

Net Profit

-16.7M

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novabay.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

NovaBay Pharmaceuticals Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker NBY. The last closing price for NovaBay Pharmaceuticals was $2.30. Over the last year, NovaBay Pharmaceuticals shares have traded in a share price range of $ 2.0501 to $ 44.80.

NovaBay Pharmaceuticals currently has 1,151,715 shares outstanding. The market capitalization of NovaBay Pharmaceuticals is $2.65 million. NovaBay Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.15.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0801	-3.64090909091	2.2	2.35	2.07	101052	2.26913191	CS
4	-0.7001	-24.8262411348	2.82	3.14	2.0501	152519	2.40279375	CS
12	-1.3801	-39.4314285714	3.5	9.079	2.0501	9216022	4.77244234	CS
26	-4.6386	-68.6335725383	6.7585	9.079	2.0501	5929572	4.9173728	CS
52	-22.1351	-91.2599464028	24.255	44.8	2.0501	3375763	6.60859314	CS
156	-757.3801	-99.7208821593	759.5	943.25	2.0501	1675123	147.88050129	CS
260	-1994.6301	-99.8938324778	1996.75	2670.5	2.0501	2030084	725.95026405	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
YGMZMingZhu Logistics Holdings Limited	$ 2.71 (68.68%)	3.74M
AEHLAntelope Enterprise Holdings Ltd	$ 7.53 (37.91%)	206.72k
ASNSActelis Networks Inc	$ 2.05 (30.57%)	2.26M
VLCNVolcon Inc	$ 4.61 (26.30%)	888.26k
KZIAKazia Therapeutics Ltd	$ 0.84 (25.71%)	12.88M
IDEXIdeanomics Inc	$ 0.62 (-29.55%)	1.15M
CINGCingulate Inc	$ 0.48 (-25.93%)	443.37k
IVPInspire Veterinary Partners Inc	$ 6.50 (-12.16%)	1.15M
CTNTCheetah Net Supply Chain Service Inc	$ 0.3865 (-12.16%)	1.03M
ZAPPZapp Electric Vehicles Group Ltd	$ 8.22 (-12.09%)	318.65k
PRSTPresto Technologies Inc	$ 0.086 (11.69%)	19.74M
KZIAKazia Therapeutics Ltd	$ 0.84 (25.71%)	12.88M
NVDANVIDIA Corporation	$ 135.58 (0.50%)	10.68M
YGMZMingZhu Logistics Holdings Limited	$ 2.71 (68.68%)	3.74M
VGLTVanguard Long Term Treasury	$ 58.11 (0.00%)	3.37M